articleTop 1% cited

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension

Journal of Hypertension · 1998 · Vol. 16(12) · pp. 1823–1829

Lisheng Liu(Chinese Academy of Medical Sciences & Peking Union Medical College)Ji Guang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)Lansheng GongGuozhang Liu(Chinese Academy of Medical Sciences & Peking Union Medical College)Jan A. Staessen✉(Geneeskundige en Gezondheidsdienst)

View via DOI Publisher page

Abstract

Antihypertensive treatment prevents stroke and other cardiovascular complications in older Chinese patients with isolated systolic hypertension. Treatment of 1000 Chinese patients for 5 years could prevent 55 deaths, 39 strokes or 59 major cardiovascular endpoints.

Blood Pressure and Hypertension Studies Hormonal Regulation and Hypertension Cardiovascular Health and Disease PreventionMedicineBlood pressureCaptoprilPlaceboCardiologyInternal medicineHydrochlorothiazideConfidence intervalDiastoleNitrendipine

MeSH terms

AgedAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsBlood PressureCaptoprilCerebrovascular DisordersChinaDiureticsDrug Therapy, CombinationFemaleHumansHydrochlorothiazideHypertensionMaleMiddle Aged

Citations

731

FWCI

25.89

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines